Contributors

Chris Allen, MS Senior Manager Facilities and Engineering, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Jack M. Anthony Founder and Principal, BioMentorz, Inc., Healdsburg, California

Norman W. Baylor, PhD President & CEO, Biologics Consulting Group, Inc., Alexandria, Virginia

John F. Beeler, PhD Director, Theranostics and Business Development bioMerieux, Cambridge, Massachusetts

Dave Boclair Manager Manufacturing Downstream Operations, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Arthur A. Boni, PhD John R. Thorne Distinguished Career Professor of Entrepreneurship, Tepper School of Business at Carnegie Mellon University, Pittsburgh, Pennsylvania

Craig C. Bradley, JD Partner, Edwards Wildman Palmer LLP, Chicago, Illinois

G. Steven Burrill CEO, Burrill & Company, San Francisco, California

Lowell W. Busenitz, PhD, MBA Academic Director, Price College Center for Entrepreneurship, University of Oklahoma, Norman, Oklahoma

Robert J. Calcaterra, DSC President, St. Louis Arch Angels, St. Louis, Missouri

John Conner, MS Vice President Manufacturing Science and Technology, Cytovance Biologics, Inc., Oklahoma City, Oklahoma

Gerry J. Elman, MS, JD Elman Technology Law, P.C., Swarthmore, Pennsylvania

Steven M. Ferguson, CLP Deputy Director, Licensing & Entrepreneurship, Office of Technology Transfer, National Institutes of Health, Rockville, Maryland

Toby Freedman, PhD President, Synapsis Search Recruiting, Portolavalley, California

Susan Garfield, DrPH Senior Vice President, GfK Custom Research LLC, Wayland, Massachusetts

James C. Greenwood President & CEO, Biotechnology Industry Organization (BIO), Washington, D.C.

Neal Gutterson, PhD President & CEO, Mendel Biotechnology, Hayward, California

Phil Haworth, PhD, JD Principal, Biomentorz, Inc. Redwood City, California

Uma S. Kaundinya, PhD, CLP President & CEO, Aavishkar Innovations Inc., Bedford, Massachusetts

Donald R. Kirsch, PhD Chief Scientific Officer, Cambria Pharmaceuticals, Cambridge, Massachusetts

Joan E. Kureczka, MSEM Founder and Principal, Kureczka/Martin Associates and The Vivant Group, San Francisco, California

Lynn Johnson Langer, PhD, MBA Director, Enterprise and Regulatory Science Programs Center for Biotechnology Education, Johns Hopkins University, Rockville, Maryland

Maria Lopez Vice President Quality Systems, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Lara V. Marks, D.Phil. (Oxon) Senior Research Fellow, Department of Social Science, Health and Medicine, King’s College, London, England

Bill Minshall, MS Senior Vice President Regulatory Affairs, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Jay Peterson Manager Manufacturing Upstream Operations, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Rabi Prusti, PhD Executive Director Quality Control, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Craig Shimasaki, PhD, MBA President & CEO, Moleculera Labs and BioSource Consulting Group, Oklahoma City, Oklahoma

Henri A. Termeer Former Chairman, CEO and President of Genzyme Corporation, Cambridge, Massachusetts

Gergana Todorova, PhD Assistant Professor, School of Business Administration, University of Miami, Coral Gables, Florida

Tom D. Walker CEO & President, TechColumbus, Inc., Columbus, Ohio

xix

Contributorsxx

Robert E. Wanerman, JD, MPH Epstein Becker Green, P.C., Washington, D.C.

Laurie R. Weingart, PhD Carnegie Bosch Professor of Organizational Behavior and Theory, Tepper School of Business at Carnegie Mellon University, Pittsburgh, Pennsylvania

Gladys B. White, PhD Adjunct Professor of Liberal Studies, Georgetown University, Washington, D.C.

Don Wuchterl Senior Vice President Operations, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Jay Z. Zhang, MS, JD Shuwen Biotech Co. Ltd., Deqing, Zhejiang Province, China and Momentous IP Ventures LLC, Salt Lake City, Utah